The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

Disclosed are a pharmaceutical composition for treatment of attention deficit hyperactivity disorder and a food composition for alleviation of attention deficit hyperactivity disorder, each of which contains as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber, wherein the compositions containing as an active ingredient a mixture extract of Longan Arillus, Salviae Miltiorrhizae Radix, Gastrodiae Rhizoma, and Liriopis seu Ophiopogonis Tuber of the present disclosure inhibits the hyperactivity of glutamate receptors, which is known to be a cause of attention deficit hyperactivity disorder, alleviates clinical symptoms (attention decrease and hyperactivity) of child patients, and shows an improvement effect in fMRI examination results, and thus can be advantageously used as a medicine for attention deficit hyperactivity disorder or a food for alleviation of attention deficit hyperactivity disorder.

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.